METROPOLITAN LIFE INSURANCE CO/NY - CRINETICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 72 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$111,674
+117.5%
3,755
+31.8%
0.01%
+200.0%
Q2 2023$51,339
+12.2%
2,8490.0%0.00%0.0%
Q1 2023$45,755
-21.6%
2,849
-10.7%
0.00%
-33.3%
Q4 2022$58,395
-6.8%
3,1910.0%0.00%0.0%
Q3 2022$62,671
+5.3%
3,1910.0%0.00%0.0%
Q2 2022$59,512
-1.8%
3,191
+15.5%
0.00%
+50.0%
Q1 2022$60,626
-82.0%
2,762
-76.6%
0.00%
-60.0%
Q4 2021$335,948
+65.2%
11,825
+22.4%
0.01%
+66.7%
Q3 2021$203,343
+11.7%
9,6600.0%0.00%0.0%
Q2 2021$182,091
+55.0%
9,660
+25.7%
0.00%
+50.0%
Q1 2021$117,442
-5.3%
7,686
-12.6%
0.00%0.0%
Q4 2020$124,055
-10.0%
8,7920.0%0.00%0.0%
Q3 2020$137,771
-10.6%
8,7920.0%0.00%
-33.3%
Q2 2020$154,036
+151.1%
8,792
+110.7%
0.00%
+200.0%
Q1 2020$61,343
-41.4%
4,1730.0%0.00%
-50.0%
Q4 2019$104,701
+352.8%
4,173
+351.1%
0.00%–
Q2 2019$23,125–925–0.00%–
 Download
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders